Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Poonamalle P. Bapsy"'
Autor:
Henning T. Mouridsen, J. Arnold Verbeek, Yan Sun, Eeva Salminen, H. A. Chaudri-Ross, Fritz Jänicke, Dominique Becquart, Justus Apffelstaedt, Beatrix Staffler, Anna Pluzanska, Magdolna Dank, Robert S. Smith, Ramon Perez-Carrion, Margaret Dugan, Mikhail Gershanovich, Alain Monnier, Mercedes Lassus, Poonamalle P. Bapsy, Harm Sleeboom, Corrado Boni, Raymond Snyder
Publikováno v:
Journal of Clinical Oncology. 19:2596-2606
PURPOSE: To compare the efficacy and tolerability of tamoxifen with that of letrozole, an oral aromatase inhibitor, with tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer. PATIENTS AND METHODS: Nine hundred seven pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1db3f2ace9ebe08ee91f8d4c3a0473
https://doi.org/10.1200/jco.2001.19.10.2596
https://doi.org/10.1200/jco.2001.19.10.2596
Autor:
V Satya Suresh, Attili, Poonamalle P, Bapsy, Chowdappa, Ramachandra, C Obula, Reddy, P S, Prabhakaran, Pratap P, Varma, Veligeti R, Chandra
Publikováno v:
Gastrointestinal cancer research : GCR. 3(5)
A variety of preoperative variables-such as perforation prior to surgery, poor nutritional status, and comorbid conditions such as diabetes-are already known to shorten relapse-free survival in patients with gastrointestinal malignancies. However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e5649eb16afd60c0cea0907849de64c
https://pubmed.ncbi.nlm.nih.gov/20084159
https://pubmed.ncbi.nlm.nih.gov/20084159
Autor:
Anna Pluzanska, Peter J. Wyld, Magdolna Dank, Raquel Lang, Dominique Becquart, Robert S. Smith, Ramon Perez-Carrion, Poonamalle P. Bapsy, Eeva Salminen, Corrado Boni, Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, H. A. Chaudri-Ross, Fritz Jaenicke, Harm Sleeboom, Justus Apffelstaedt, Alain Monnier, Ajay Bhatnagar, Raymond Snyder
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(11)
Purpose: To analyze overall survival (OS) and update efficacy data for letrozole versus tamoxifen as first-line therapy in postmenopausal women with locally advanced or metastatic breast cancer. Patients and Methods: This multicenter phase III trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34dce635009b5b10ef798601b918e68f
https://pubmed.ncbi.nlm.nih.gov/15284276
https://pubmed.ncbi.nlm.nih.gov/15284276